| Secondary |
| Drug Use For Unknown Indication |
35.1% |
| Product Used For Unknown Indication |
14.8% |
| Depression |
10.2% |
| Hypertension |
7.7% |
| Anxiety |
3.7% |
| Insomnia |
3.1% |
| Head Injury |
2.5% |
| Parkinson's Disease |
2.5% |
| Pain |
2.3% |
| Gout |
2.1% |
| Ill-defined Disorder |
2.1% |
| Unevaluable Event |
2.1% |
| Dementia Alzheimer's Type |
1.9% |
| Epilepsy |
1.7% |
| Spondylitis |
1.7% |
| Childhood Psychosis |
1.5% |
| Hypothyroidism |
1.5% |
| Breast Cancer Metastatic |
1.2% |
| Carotid Artery Thrombosis |
1.2% |
| Hiv Infection |
1.2% |
|
| Hyponatraemia |
10.8% |
| Vomiting |
10.8% |
| Agranulocytosis |
9.7% |
| Epilepsy |
6.5% |
| Cytolytic Hepatitis |
5.4% |
| Fine Motor Delay |
5.4% |
| Guillain-barre Syndrome |
5.4% |
| International Normalised Ratio Increased |
4.3% |
| Ischaemic Stroke |
4.3% |
| Renal Failure Acute |
4.3% |
| Rhabdomyolysis |
4.3% |
| Thrombocytopenia |
4.3% |
| Tongue Necrosis |
4.3% |
| Bacteraemia |
3.2% |
| Neurological Decompensation |
3.2% |
| Pancytopenia |
3.2% |
| Suicide Attempt |
3.2% |
| Vertigo |
3.2% |
| Cerebellar Haematoma |
2.2% |
| Cholelithiasis |
2.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
30.3% |
| Product Used For Unknown Indication |
19.9% |
| Depression |
13.4% |
| Hypertension |
5.8% |
| Pain |
3.9% |
| Anxiety |
2.9% |
| Atrial Fibrillation |
2.9% |
| Osteoporosis |
2.6% |
| Prostate Cancer |
2.5% |
| Prophylaxis |
2.3% |
| Insomnia |
1.8% |
| Constipation |
1.5% |
| Thrombosis Prophylaxis |
1.4% |
| Breast Cancer |
1.3% |
| Hypercholesterolaemia |
1.3% |
| Epilepsy |
1.3% |
| Factor Viii Inhibition |
1.3% |
| Parkinson's Disease |
1.3% |
| Tuberculosis |
1.3% |
| Arrhythmia |
1.1% |
|
| Thrombocytopenia |
8.0% |
| Urinary Tract Infection |
8.0% |
| Renal Failure Acute |
6.5% |
| Gamma-glutamyltransferase Increased |
5.8% |
| Pancytopenia |
5.8% |
| Vomiting |
5.8% |
| Hyponatraemia |
5.1% |
| International Normalised Ratio Increased |
5.1% |
| Colitis Ischaemic |
4.3% |
| Dermatitis Exfoliative |
4.3% |
| Febrile Bone Marrow Aplasia |
4.3% |
| General Physical Health Deterioration |
4.3% |
| Pain |
4.3% |
| Pulmonary Embolism |
4.3% |
| Urinary Retention |
4.3% |
| Vena Cava Thrombosis |
4.3% |
| Weight Decreased |
4.3% |
| Drug Eruption |
3.6% |
| Drug Interaction |
3.6% |
| Malaise |
3.6% |
|
| Interacting |
| Drug Use For Unknown Indication |
100.0% |
|
| Drug Interaction |
50.0% |
| Vertigo |
50.0% |
|
